Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Details for Australian Patent Application No. 2009242720 (hide)

Owner Merck Patent GmbH

Inventors Charon, Christine; Valeur, Eric; Elbawab, Samer; Botton, Gerard; Kergoat, Micheline

Agent Davies Collison Cave

Pub. Number AU-A-2009242720

PCT Pub. Number WO2009/132739

Priority 08008165.6 29.04.08 EP

Filing date 31 March 2009

Wipo publication date 5 November 2009

International Classifications

C07D 241/18 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/38 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/132739 Priority application(s): WO2009/132739

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009242728-Equipment for the straightening of deformed electrolysis potshells, in particular for aluminium molten-bath electrolysis

2009242713-Apparatus for stimulating a healing process